HDL: The underdog in the battle against atherosclerosis

Yaakov Henkin, Robert A. Kreisberg

Research output: Contribution to journalArticlepeer-review


The central role of lipid abnormalities in the genesis of atherosclerosis has focused on cholesterol. Therapy has concentrated on lowering cholesterol levels, especially cholesterol associated with low-density lipoprotein (LDL) particles. The circulating high-density lipoprotein (HDL) cholesterol concentration, however, appears to be a strong modifier of LDL cholesterol-associated risk for coronary artery disease. This article reviews the current state of our knowledge regarding HDL and explores the rational application of HDL measurements to patients with lipid abnormalities.

Original languageEnglish
Pages (from-to)122-132
Number of pages11
Issue number2
StatePublished - 1 Jan 1992
Externally publishedYes

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism


Dive into the research topics of 'HDL: The underdog in the battle against atherosclerosis'. Together they form a unique fingerprint.

Cite this